Related Experiment Videos
Antiphospholipid antibodies in pediatrics
1Oklahoma Medical Research Foundation and the Oklahoma University Medical Center, 825 Northeast 13th Street, MS #24, Oklahoma City, OK 73104, USA. ana-quintero@omrf.ouhsc.edu
Insights
Antiphospholipid syndrome (APS) involves blood clots and low platelets, diagnosed by specific antibodies and a thrombotic event. Treatment for pediatric APS includes heparin and low-dose aspirin.
Area of Science:
- Pediatric Hematology
- Immunology
- Vascular Medicine
Background:
- Antiphospholipid antibody syndrome (APS) is linked to thrombosis, thrombocytopenia, hemolytic anemia, livedo reticularis, neurological issues, and recurrent fetal loss.
- Diagnosis requires elevated anticardiolipin antibodies and lupus anticoagulant alongside a thrombotic event.
- APS can be primary or secondary to conditions like systemic lupus erythematosus.
Purpose of the Study:
- To summarize the key aspects of Antiphospholipid Antibody Syndrome in pediatric patients.
- To highlight diagnostic criteria and common clinical manifestations.
- To outline current therapeutic recommendations.
Main Methods:
- Literature review of Antiphospholipid Antibody Syndrome in pediatric populations.
- Analysis of diagnostic markers including anticardiolipin antibodies and lupus anticoagulant.
- Review of established treatment protocols for pediatric APS.
Main Results:
- Antiphospholipid antibodies are a significant cause of thrombotic events in children.
- Common clinical features include vascular thrombosis and thrombocytopenia.
- The syndrome can manifest independently or secondary to other autoimmune diseases.
Conclusions:
- Antiphospholipid syndrome is a serious condition in children requiring prompt diagnosis.
- Effective management involves anticoagulation therapy.
- Heparin and low-dose aspirin are recommended for pediatric patients with APS.
Abstract:
Antiphospholipid antibody syndrome has been associated with vascular thrombosis, thrombocytopenia, hemolytic anemia, livedo reticularis, neurologic disorders, and recurrent fetal loss. The diagnosis of antiphospholipid syndrome is given in the presence of an elevated anticardiolipin antibody lupus anticoagulant in addition to a thrombotic event. Antiphospholipid antibodies are responsible for a majority of thrombotic events in children. These antibodies can present as a primary syndrome or secondary to other diseases, such as systemic lupus erythematosus. Anticoagulation therapy with heparin and low-dose aspirin is the recommended treatment in pediatric patients.